| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-08 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.0006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.14 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.004 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |